Last reviewed · How we verify
Arm 1 - DehydraTECH-CBD alone — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Arm 1 - DehydraTECH-CBD alone (Arm 1 - DehydraTECH-CBD alone) — Lexaria Bioscience Corp..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Arm 1 - DehydraTECH-CBD alone TARGET | Arm 1 - DehydraTECH-CBD alone | Lexaria Bioscience Corp. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Arm 1 - DehydraTECH-CBD alone CI watch — RSS
- Arm 1 - DehydraTECH-CBD alone CI watch — Atom
- Arm 1 - DehydraTECH-CBD alone CI watch — JSON
- Arm 1 - DehydraTECH-CBD alone alone — RSS
Cite this brief
Drug Landscape (2026). Arm 1 - DehydraTECH-CBD alone — Competitive Intelligence Brief. https://druglandscape.com/ci/arm-1-dehydratech-cbd-alone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab